BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheng J, Sun H, Yu FB, Li B, Zhang Y, Zhu YT. The Role of Cyclooxygenase-2 in Colorectal Cancer. Int J Med Sci 2020;17:1095-101. [PMID: 32410839 DOI: 10.7150/ijms.44439] [Cited by in Crossref: 11] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Saghi H, Mirzavi F, Afshari AR, Jalili-nik M, Mashkani B, Soukhtanloo M. Bee venom induces anti-tumor effects in HT-29 colon cancer cells through regulation of cell proliferation and apoptosis. Biologia. [DOI: 10.1007/s11756-022-01201-9] [Reference Citation Analysis]
2 Rishmawi S, Haddad F, Dokmak G, Karaman R. A Comprehensive Review on the Anti-Cancer Effects of Oleuropein. Life (Basel) 2022;12:1140. [PMID: 36013319 DOI: 10.3390/life12081140] [Reference Citation Analysis]
3 Sobolewski C, Dubuquoy L, Legrand N. MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes. Cancers 2022;14:3516. [DOI: 10.3390/cancers14143516] [Reference Citation Analysis]
4 Zafari N, Khosravi F, Rezaee Z, Esfandyari S, Bahiraei M, Bahramy A, Ferns GA, Avan A. The role of the tumor microenvironment in colorectal cancer and the potential therapeutic approaches. J Clin Lab Anal 2022;:e24585. [PMID: 35808903 DOI: 10.1002/jcla.24585] [Reference Citation Analysis]
5 Janicka N, Sałek A, Sawińska M, Kuchar E, Wiela-hojeńska A, Karłowicz-bodalska K. Effects of Non-Opioid Analgesics on the Cell Membrane of Skin and Gastrointestinal Cancers. IJMS 2022;23:7096. [DOI: 10.3390/ijms23137096] [Reference Citation Analysis]
6 El-Sayed NNE, Almaneai NM, Ben Bacha A, El-Ashrey MK, Al-Zaben MI, Almarhoon ZM. Biological Evaluation, Molecular Docking Analyses, and ADME Profiling of Certain New Quinazolinones as Anti-colorectal Agents. ACS Omega 2022;7:18443-58. [PMID: 35694504 DOI: 10.1021/acsomega.2c00812] [Reference Citation Analysis]
7 Wang X, Zhao S, Wang Z, Gao T. Platelets involved tumor cell EMT during circulation: communications and interventions. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00887-3] [Reference Citation Analysis]
8 Singh P, Waghambare P, Khan T, Omri A. Colorectal cancer management: Strategies in drug delivery. Expert Opin Drug Deliv 2022. [PMID: 35656670 DOI: 10.1080/17425247.2022.2084531] [Reference Citation Analysis]
9 Jacques C, Marchesi I, Fiorentino FP, Chatelais M, Lilli NL, Appel K, Lejeune B, Floris I. A Micro-Immunotherapy Sequential Medicine MIM-seq Displays Immunomodulatory Effects on Human Macrophages and Anti-Tumor Properties towards In Vitro 2D and 3D Models of Colon Carcinoma and in an In Vivo Subcutaneous Xenograft Colon Carcinoma Model. Int J Mol Sci 2022;23:6059. [PMID: 35682738 DOI: 10.3390/ijms23116059] [Reference Citation Analysis]
10 Kast RE, Alfieri A, Assi HI, Burns TC, Elyamany AM, Gonzalez-Cao M, Karpel-Massler G, Marosi C, Salacz ME, Sardi I, Van Vlierberghe P, Zaghloul MS, Halatsch ME. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers (Basel) 2022;14:2563. [PMID: 35626167 DOI: 10.3390/cancers14102563] [Reference Citation Analysis]
11 El Zarif T, Yibirin M, De Oliveira-Gomes D, Machaalani M, Nawfal R, Bittar G, Bahmad HF, Bitar N. Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing. Cancers (Basel) 2022;14:2105. [PMID: 35565237 DOI: 10.3390/cancers14092105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Kolawole OR, Kashfi K. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase. Int J Mol Sci 2022;23:1432. [PMID: 35163356 DOI: 10.3390/ijms23031432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Cykowiak M, Kleszcz R, Kucińska M, Paluszczak J, Szaefer H, Plewiński A, Piotrowska-Kempisty H, Murias M, Krajka-Kuźniak V. Attenuation of Pancreatic Cancer In Vitro and In Vivo via Modulation of Nrf2 and NF-κB Signaling Pathways by Natural Compounds. Cells 2021;10:3556. [PMID: 34944062 DOI: 10.3390/cells10123556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lewandowska P, Szczuka I, Bednarz-Misa I, Szczęśniak-Sięga BM, Neubauer K, Mierzchała-Pasierb M, Zawadzki M, Witkiewicz W, Krzystek-Korpacka M. Modulating Properties of Piroxicam, Meloxicam and Oxicam Analogues against Macrophage-Associated Chemokines in Colorectal Cancer. Molecules 2021;26:7375. [PMID: 34885960 DOI: 10.3390/molecules26237375] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Neganova M, Liu J, Aleksandrova Y, Klochkov S, Fan R. Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment. Cancers (Basel) 2021;13:6062. [PMID: 34885171 DOI: 10.3390/cancers13236062] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Vekic J, Zeljkovic A, Stefanovic A, Giglio RV, Ciaccio M, Rizzo M. Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents. Int J Mol Sci 2021;22:12409. [PMID: 34830295 DOI: 10.3390/ijms222212409] [Reference Citation Analysis]
17 Szoka L, Nazaruk J, Stocki M, Isidorov V. Santin and cirsimaritin from Betula pubescens and Betula pendula buds induce apoptosis in human digestive system cancer cells. J Cell Mol Med 2021;25:11085-96. [PMID: 34755444 DOI: 10.1111/jcmm.17031] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Fernandes MT, Yassuda V, Bragança J, Link W, Ferreira BI, De Sousa-coelho AL. Tribbles Gene Expression Profiles in Colorectal Cancer. GastrointestDisord 2021;3:218-36. [DOI: 10.3390/gidisord3040021] [Reference Citation Analysis]
19 Masato M, Miyata Y, Kurata H, Ito H, Mitsunari K, Asai A, Nakamura Y, Araki K, Mukae Y, Matsuda T, Harada J, Matsuo T, Ohba K, Sakai H. Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal model. Sci Rep 2021;11:20279. [PMID: 34645904 DOI: 10.1038/s41598-021-99694-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Berbecka M, Forma A, Baj J, Furtak-Niczyporuk M, Maciejewski R, Sitarz R. A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy. J Clin Med 2021;10:4443. [PMID: 34640461 DOI: 10.3390/jcm10194443] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Marongiu L, Allgayer H. Viruses in colorectal cancer. Mol Oncol 2021. [PMID: 34514694 DOI: 10.1002/1878-0261.13100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Ezenkwa US, Okolo CA, Ogun GO, Akere A, Ogunbiyi OJ. Cyclooxygenase-2 expression in colorectal carcinoma, adenomatous polyps and non-tumour bearing margins of resection tissues in a cohort of black Africans. PLoS One 2021;16:e0255235. [PMID: 34314467 DOI: 10.1371/journal.pone.0255235] [Reference Citation Analysis]
23 El-Miligy MMM, Al-Kubeisi AK, El-Zemity SR, Nassra RA, Abu-Serie MM, Hazzaa AA. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes. Bioorg Chem 2021;115:105171. [PMID: 34303896 DOI: 10.1016/j.bioorg.2021.105171] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
24 Gómez-Valenzuela F, Escobar E, Pérez-Tomás R, Montecinos VP. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Front Oncol 2021;11:686792. [PMID: 34178680 DOI: 10.3389/fonc.2021.686792] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
25 Torreggiani E, Bononi I, Pietrobon S, Mazzoni E, Guerra G, Feo C, Martini F, Tognon M. Colorectal Carcinoma Affected Patients Are Significantly Poor Responders Against the Oncogenic JC Polyomavirus. Front Immunol 2021;12:632129. [PMID: 34113338 DOI: 10.3389/fimmu.2021.632129] [Reference Citation Analysis]
26 El-Sayed NNE, Al-Otaibi TM, Alonazi M, Masand VH, Barakat A, Almarhoon ZM, Ben Bacha A. Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SRA, Molecular Docking, and ADMET Analyses. Molecules 2021;26:3121. [PMID: 34071141 DOI: 10.3390/molecules26113121] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Schultz F, Osuji OF, Wack B, Anywar G, Garbe LA. Antiinflammatory Medicinal Plants from the Ugandan Greater Mpigi Region Act as Potent Inhibitors in the COX-2/PGH2 Pathway. Plants (Basel) 2021;10:351. [PMID: 33673238 DOI: 10.3390/plants10020351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
28 Huang HW, Chang CC, Wang CS, Lin KH. Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development. Cells 2021;10:E67. [PMID: 33406733 DOI: 10.3390/cells10010067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
29 Marônek M, Link R, Monteleone G, Gardlík R, Stolfi C. Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? Int J Mol Sci 2020;21:E8133. [PMID: 33143318 DOI: 10.3390/ijms21218133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
30 Hermanowicz JM, Kwiatkowska I, Pawlak D. Important players in carcinogenesis as potential targets in cancer therapy: an update. Oncotarget 2020;11:3078-101. [PMID: 32850012 DOI: 10.18632/oncotarget.27689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Iwaniak A, Minkiewicz P, Pliszka M, Mogut D, Darewicz M. Characteristics of Biopeptides Released In Silico from Collagens Using Quantitative Parameters. Foods 2020;9:E965. [PMID: 32708318 DOI: 10.3390/foods9070965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
32 Al Abdulmonem W, Rasheed Z, Aljohani ASM, Omran OM, Rasheed N, Alkhamiss A, A M Al Salloom A, Alhumaydhi F, Alblihed MA, Al Ssadh H, Khan MI, Fernández N. Absence of CD74 Isoform at 41kDa Prevents the Heterotypic Associations between CD74 and CD44 in Human Lung Adenocarcinoma-derived Cells. Immunol Invest 2020;:1-15. [PMID: 32646312 DOI: 10.1080/08820139.2020.1790594] [Cited by in F6Publishing: 1] [Reference Citation Analysis]